Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis

30 Jun 2022

Abstract excerpt

Idiopathic pulmonary fibrosis (IPF), a disorder observed mostly in older human beings, is characterised by chronic and progressive lung scarring leading to an irreversible decline in lung function. This health condition has a dismal prognosis and the currently available drugs only delay but fail to reverse the progression of lung damage. Consequently, it becomes imperative to discover improved therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Share to Peptidase Inhibition and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36061031
DOI: 10.1016/j.heliyon.2022.e09773

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosisPMID 36061031Read ↗

Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic OptionSemantic proximity Read ↗

Histone deacetylases: potential therapeutic targets for idiopathic pulmonary fibrosisSemantic proximity Read ↗

More than a Genetic Code: Epigenetics of Lung FibrosisSemantic proximity Read ↗

The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosisSemantic proximity Read ↗

The role of epigenetics in pulmonary fibrosis: recent advances in mechanistic insights and therapeutic implicationsSemantic proximity Read ↗

Epigenetics in idiopathic pulmonary fibrosisSemantic proximity Read ↗

TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repressionSemantic proximity Read ↗

A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy.Semantic proximity Read ↗

Emerging Epigenetic Therapies for the Treatment of Cardiac FibrosisSemantic proximity Read ↗

Epigenetic hallmarks in pulmonary fibrosis: New advances and perspectivesSemantic proximity Read ↗

Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary FibrosisSemantic proximity Read ↗

Molecular pathways and role of epigenetics in the idiopathic pulmonary fibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.